Gould, Rebecca L. http://orcid.org/0000-0001-9283-1626
Rawlinson, Charlotte
Thompson, Ben
Weeks, Kirsty
Gossage-Worrall, Rebecca
Cantrill, Hannah
Serfaty, Marc A.
Graham, Christopher D.
McCracken, Lance M.
White, David
Howard, Robert J.
Bursnall, Matt
Bradburn, Mike
Al-Chalabi, Ammar
Orrell, Richard
Chhetri, Suresh K.
Noad, Rupert
Radunovic, Aleksandar
Williams, Tim
Young, Carolyn A.
Dick, David
Lawrence, Vanessa
Goldstein, Laura H.
Young, Tracey
Ealing, John
McLeod, Hamish
Williams, Nicola
Weatherly, Helen
Cave, Richard
Chiwera, Theresa
Pagnini, Francesco
Cooper, Cindy
Shaw, Pamela J.
McDermott, Christopher J.
Burns, Annmarie
Dancyger, Caroline
Dee, Annily
Henley, Susie
Howell, Mark
Kishita, Naoko
Makin, Selina
Mayberry, Emily
Oliver, Mark
Richards, Alexandra
Robinson, Emma
Tallentire, Liz
,
Funding for this research was provided by:
Health Technology Assessment Programme (16/81/01)
Motor Neurone Disease Association (Gould/Jul17/936-794)
Article History
Received: 13 March 2023
Accepted: 27 June 2023
First Online: 7 July 2023
Declarations
:
: Ethical approval was granted by the London-Dulwich Research Ethics Committee (18/LO/0227). All eligible participants were invited to provide fully informed written consent, verbal consent (for those who could not provide written consent due to mobility issues), or consent via the use of a communication aid to participate in the trial, in line with Sheffield Clinical Trial Research Unit’s standard operating procedures and as approved by the London-Dulwich Research Ethics Committee. An independent witness was asked to sign the consent form to verify the consent taken in all cases where non-written consent was obtained.
: Not applicable.
: The authors declare that they have no competing interests.